Sarepta Therapeutics (SRPT) Invested Capital (2010 - 2025)
Sarepta Therapeutics' (SRPT) quarterly Invested Capital came in at $36.0 million in Q3 2025, down 60.7% year-on-year from $91.6 million in Q3 2024, and down 60.7% quarter-over-quarter from $91.6 million in Q3 2024.
Sarepta Therapeutics (SRPT) Invested Capital (2010 - 2025) Analysis & Trends
Sarepta Therapeutics' Invested Capital history runs 12 years deep, the most recent figure standing at $36.0 million for Q3 2025.
- On a quarterly basis, Invested Capital fell 60.7% year-over-year to $36.0 million in Q3 2025; TTM through Mar 2026 was $36.0 million, a 80.34% decrease from a year earlier, with the FY2023 full-year figure at $105.5 million, changed N/A from the prior year.
- Invested Capital declined to $36.0 million in Q3 2025 per SRPT's latest filing, from $91.6 million in the prior quarter.
- Across five years, Invested Capital topped out at $105.6 million in Q1 2024 and bottomed at $36.0 million in Q3 2025.
- The 3-year median for Invested Capital is $91.6 million (2024), against an average of $86.0 million.
- Biggest YoY gain for Invested Capital was 60.7% in 2025; the steepest drop was 60.7% in 2025.
- Year by year, Invested Capital stood at $105.5 million in 2023, then fell by 13.17% to $91.6 million in 2024, then slumped by 60.7% to $36.0 million in 2025.
- Per Business Quant, the three latest SRPT Invested Capital figures stand at $36.0 million (Q3 2025), $91.6 million (Q3 2024), and $91.5 million (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2024 | 91.60 Mn |
| Jun 30, 2024 | 91.51 Mn |
| Mar 31, 2024 | 105.59 Mn |
| Dec 31, 2023 | 105.48 Mn |
| Jun 30, 2018 | 9.51 Mn |
| Mar 31, 2018 | 3.45 Mn |
| Dec 31, 2017 | 6.18 Mn |
| Sep 30, 2017 | 4.73 Mn |
| Jun 30, 2017 | 11.22 Mn |
| Mar 31, 2017 | 11.35 Mn |
| Dec 31, 2016 | 10.11 Mn |
| Sep 30, 2016 | 10.11 Mn |
| Jun 30, 2016 | 10.11 Mn |
| Mar 31, 2016 | 7.60 Mn |
| Dec 31, 2015 | 5.94 Mn |
| Sep 30, 2015 | 3.44 Mn |
| Jun 30, 2015 | 100,000.00 |
| Mar 31, 2015 | 99,000.00 |
| Dec 31, 2014 | 98,000.00 |